Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identification of the Zdhhc20 KO transcriptome

ABSTRACT: Identification of the Zdhhc20 KO transcriptome

PROVIDER: PRJNA911909 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22725978.fastq.gz	Fastqsanger.gz
	SRR22725979.fastq.gz	Fastqsanger.gz
	SRR22725980.fastq.gz	Fastqsanger.gz
	SRR22725981.fastq.gz	Fastqsanger.gz
	SRR22725982.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

Dyw2-DYW2_OTP100: Identification of the transcriptome defects (nuclear and organelles) of the T-DNA KO mutants of DYW2 and OTP100

Project description:ngs2016_08_dyw2-dyw2-Identification of the transcriptome defects (nuclear and organelles) of the T-DNA KO mutants of DYW2 and OTP100-TheT-DNA KO mutations are embryo-ethal for DYW2 and OTP100 so the homozygous mutants were produced by a temporal embryo-specific complementation using the promoter of ABI3. The resulting homozygous mutants were compared to their WT siblings. The T-DNA lines were GK_332A07 for DYW2 and SAIL_784_A11 for OTP100

2018-01-22 | GSE100298 | GEO

Identification of the Zdhhc20 KO transcriptome

Project description:Metastasis is one of the defining features of pancreatic ductal adenocarcinoma (PDAC) that contributes to poor prognosis. In this study, the palmitoyl transferase ZDHHC20 was identified in an in vivo shRNA screen as critical for metastatic outgrowth, with no effect on proliferation and migration in vitro, or primary PDAC growth in mice. In this experiment, we sought to determine the changes in the transcriptome of Zdhhc20 KO cells that were previously generated using CRISPR/Cas9 and com,pare them with control cells.

2023-02-09 | GSE220914 | GEO

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Project description:This first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess KO-2806, a farnesyl transferase inhibitor (FTI), as a monotherapy and in combination, in adult patients with advanced solid tumors.

| 91122 | ecrin-mdr-crc

Striatal astrocyte Crym KO transcriptome

Project description:Striatal astrocyte Crym KO transcriptome

| PRJNA950070 | ENA

Transcriptome profiling of Actr3 KO mIMCD3 cells

Project description:Actr3 WT (control) and Actr3 KO mIMCD3 cells were generated using CRISPR/Cas9 and independent gRNAs for control and KO cell lines. Single cells clones (Ctrl.-1, Crtl.-2, KO-1, KO-2) were selected and validated by western blotting confirming loss of Actr3 in KO cell lines on protein level. Transcriptome profiling (RNA-Sequencing) and differential gene expression analysis of independent replicates per cell line was performed.

2025-10-16 | GSE287610 | GEO

Transcriptome analysis of CHD8 ko mice

Project description:Transcriptome analysis of CHD8 ko mice

| PRJNA757969 | ENA

Transcriptome profiling of starved Actr3 KO mIMCD3 cells

Project description:Actr3 WT (control), Actr3 KO and Actr3-Ift88 double KO mIMCD3 cells were generated using CRISPR/Cas9. Single cells clones (Actr3 Ctrl.-1, Actr3 KO-1, Actr3-Ift88 dKO) were selected and validated by western blotting confirming loss of Actr3 or Ift88 in KO cell lines on protein level. Transcriptome profiling (RNA-Sequencing) and differential gene expression analysis of three independent replicates of starved (ciliated) Actr3 Ctrl.-1, Actr3 KO-1, Actr3-KO Ift88-KO (dKO) and 0.5 µM Ciliobrevin D treated Actr3 KO-1 cells was performed.

2025-10-16 | GSE287677 | GEO

Transcriptome of Dmrt3 KO, Dmrt5 KO, Dmrt3 Dmrt5 double KO and wildtype cortical tissue at E12.5.

Project description:Transcriptome of Dmrt3 KO, Dmrt5 KO, Dmrt3 Dmrt5 double KO and wildtype cortical tissue at E12.5.

| PRJNA427815 | ENA

Identification of Jmjd2a KO regulated genes in the mouse hearts

Project description:Identification of Jmjd2a KO regulated genes in the mouse hearts

| PRJNA717262 | ENA

Transcriptome profiling of ANXA4 KO in A498 cells

Project description:ANXA4 WT (control) and ANXA4 KO in A498 kidney cancer cells was generated using CRISPR/Cas9 and two independent gRNAs for control and two independent gRNAs targeting ANXA4. Single cells clones (Ctrl.-1, Crtl.-2, KO-1, KO-2) were selected and validated by western blotting confirming loss of ANXA4 in KO cell lines on protein level. Transcriptome profiling (RNA-Sequencing) and differential gene expression analysis of 2 independent replicates per cell line was performed (resulting in 4 control and 4 ANXA4 KO sequencings). ANXA4 KO cells exhibit transcriptional changes compared to WT cells including upregulation of the ETS transcription factor ELF3 and regulation of Matrisome genes.

2024-05-28 | GSE267754 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data